RT Journal Article
SR Electronic
T1 Genome-wide association study of autopsy-confirmed Multiple System Atrophy identifies common variants near <em>ZIC1</em> and <em>ZIC4</em>
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.11.21265915
DO 10.1101/2021.11.11.21265915
A1 Hopfner, Franziska
A1 Tietz, Anja K.
A1 Ruf, Viktoria
A1 Ross, Owen A.
A1 Koga, Shunsuke
A1 Dickson, Dennis
A1 Aguzzi, Adriano
A1 Attems, Johannes
A1 Beach, Thomas
A1 Beller, Allison
A1 van Deerlin, Vivianna
A1 Desplats, Paula
A1 Deuschl, Günther
A1 Duyckaerts, Charles
A1 Ellinghaus, David
A1 Evsyukov, Valentin
A1 Flanagan, Margaret Ellen
A1 Franke, Andre
A1 Frosch, Matthew P.
A1 Gearing, Marla
A1 Gelpi, Ellen
A1 Ghetti, Bernardino
A1 Glass, Jonathan D.
A1 Grinberg, Lea T.
A1 Halliday, Glenda
A1 Helbig, Ingo
A1 Höllerhage, Matthias
A1 Huitinga, Inge
A1 Irwin, David John
A1 Keene, Dirk C.
A1 Kovacs, Gabor G.
A1 Lee, Edward B.
A1 Levin, Johannes
A1 Martí, Maria J.
A1 Mackenzie, Ian
A1 McKeith, Ian
A1 Mclean, Catriona
A1 Mollenhauer, Brit
A1 Neumann, Manuela
A1 Newell, Kathy L.
A1 Pantelyat, Alex
A1 Pendziwiat, Manuela
A1 Peters, Annette
A1 Porcel, Laura Molina
A1 Rabano, Alberto
A1 Matěj, Radoslav
A1 Rajput, Alex
A1 Rajput, Ali
A1 Reimann, Regina
A1 Scott, William K.
A1 Seeley, William
A1 Selvackadunco, Sashika
A1 Simuni, Tanya
A1 Stadelmann, Christine
A1 Svenningsson, Per
A1 Thomas, Alan
A1 Trenkwalder, Claudia
A1 Troakes, Claire
A1 Trojanowski, John Q.
A1 White, Charles L.
A1 Xie, Tao
A1 Ximelis, Teresa
A1 Yebenes, Justo
A1 ,
A1 Müller, Ulrich
A1 Schellenberg, Gerard D.
A1 Herms, Jochen
A1 Kuhlenbäumer, Gregor
A1 Höglinger, Günter
YR 2021
UL http://medrxiv.org/content/early/2021/11/12/2021.11.11.21265915.abstract
AB Multiple System Atrophy is a rare neurodegenerative disease with alpha-synuclein aggregation in glial cytoplasmic inclusions and either predominant olivopontocerebellar atrophy or striatonigral degeneration, leading to dysautonomia, parkinsonism, and cerebellar ataxia. One prior genome-wide association study in mainly clinically diagnosed patients with Multiple System Atrophy failed to identify genetic variants predisposing for the disease. Since the clinical diagnosis of Multiple System Atrophy yields a high rate of misdiagnosis when compared to the neuropathological gold standard, we studied common genetic variation in only autopsy-confirmed cases (N = 731) and controls (N = 2,898).The most strongly disease-associated markers were rs16859966 on chromosome 3 (P = 8.6 × 10−7, odds ratio (OR) = 1.58, [95% confidence interval (CI) = 1.32-1.89]), rs7013955 on chromosome 8 (P = 3.7 × 10−6, OR = 1.8 [1.40-2.31]), and rs116607983 on chromosome 4 (P = 4.0 × 10−6, OR = 2.93 [1.86-4.63]), all of which were supported by at least one additional genotyped and several imputed single nucleotide polymorphisms with P-values below 5 × 10−5. The genes closest to the chromosome 3 locus are ZIC1 and ZIC4 encoding the zinc finger proteins of cerebellum 1 and 4 (ZIC1 and ZIC4).Since mutations of ZIC1 and ZIC4 and paraneoplastic autoantibodies directed against ZIC4 are associated with severe cerebellar dysfunction, we conducted immunohistochemical analyses in brain tissue of the frontal cortex and the cerebellum from 24 Multiple System Atrophy patients. Strong immunohistochemical expression of ZIC4 was detected in a subset of neurons of the dentate nucleus in all healthy controls and in patients with striatonigral degeneration, whereas ZIC4 positive neurons were significantly reduced in patients with olivopontocerebellar atrophy.These findings point to a potential ZIC4-mediated vulnerability of neurons in Multiple System Atrophy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study received support from the Deutsche Parkinson Gesellschaft, the Else-Kroner-Fresenius Stiftung, the CurePSP foundation, the Alzheimers Disease Genetics Consortium (ADGC) NIA grant U01AG032984, the National Alzheimers Coordinating Center (NACC) NIA grant U01 AG016976 and the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germanys Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy ID 390857198), the Hannover Cluster RESIST (EXC 2155 ID 390874280) and the Kiel Cluster (EXC2167, Precision Medicine in Chronic Inflammation (PMI)), the DFG grant (HO2402/18-1), the Volkswagen Stiftung (Niedersachsisches Vorab), the Petermax-Muller Foundation (Etiology and Therapy of Synucleinopathies and Tauopathies), and ERARE18-124 (MSA-omics) under the frame of E-Rare-3, the ERA-Net for Research on Rare Diseases. Data for this study were prepared, archived, and distributed by the National Institute on Aging Alzheimers Disease Data Storage Site (NIAGADS) at the University of Pennsylvania (NIA grant U24-AG041689). Samples from the National Cell Repository for Alzheimers Disease (NCRAD), which receives government support under a cooperative agreement grant (U24 AG21886) awarded by the National Institute on Aging (NIA), were used in this study. We thank contributors who collected samples used in this study, as well as patients and their families, whose help and participation made this work possible; A part of the samples was collected at the Mayo Clinic. The Mayo Clinic is an American Parkinson Disease Association (APDA) Mayo Clinic Information and Referral Center, an APDA Center for Advanced Research, and is supported by a Lewy Body Dementia Center Without Walls U54NS110435 (to D.W.D. &amp; O.A.R.). The brain bank was supported, in part, by the Mangurian Foundation Lewy Body Dementia Program at Mayo Clinic. The London Neurodegenerative Diseases Brain Bank, Kings College London is supported by the MRC (Medical Research Council, UK) and the Brains for Dementia Research project (jointly funded by the Alzheimer's Society and Alzheimer's Research UK). Data were contributed to this study by the Center on Alpha-synuclein Strains in Alzheimer Disease &amp; Related Dementias at the University of Pennsylvania Perelman School of Medicine (U19 AG062418, Trojanowski JQ-PI) and the former Morris K. Udall Center at the University of Pennsylvania Perelman School of Medicine (P50 NS053488, Trojanowski JQ-PI), NIA P01-AG066597 and AG072979 (formerly AG010124). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethikkommission der Fakultat fur Medizin der Technischen Universitat MunchenI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript